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Objective-To assess treatment with fludrocortisone in vasodepressor carotid sinus syndrome.
Patients and methods-Eleven patients, mean (SD) age 83 (5) years, with daily dizzy episodes and a median of five (range two to 20) syncopal episodes over a median of one year were studied. All had vasodepressor carotid sinus syndrome (> 50 mm Hg fall in systolic blood pressure during carotid sinus massage independent of bradycardia). Carotid sinus massage was carried out while the patient was supine and upright (tilt table) before and after 600 ug intravenous atropine. Phasic heart rate and blood pressure recordings were monitored throughout. The study was repeated after 100 ug of fludrocortisone daily by mouth for two weeks. Patients continued to take fludrocortisone for a six month follow up period.
Results-Baseline systolic blood pressure was (mean (SD)) 169 (31) mm Hg and the RR interval was 770 (150) ms. After carotid sinus massage, systolic blood pressure fell to 113 (27) mm Hg (p < 0-01) and RR was 1060 (210) ms (NS). The vasodepressor response was 56 (12) mm Hg. Baseline systolic blood pressure after two weeks of fludrocortisone treatment was 171 (37) mm Hg (NS); but the fall in systolic blood pressure during carotid sinus massage was significantly reduced (32 (14) Orthostatic hypotension is present in up to 20% of patients with vasodepressor carotid sinus syndrome.246 Fludrocortisone is of benefit in orthostatic hypotension, acting by direct vasoconstriction of venous capacitance vessels, through sodium retention and increased vascular sensitivity to circulating catecholamines.78
Our study was to determine whether fludrocortisone is beneficial in the treatment of symptomatic vasodepressor carotid sinus syndrome.
Patients and methods The study group comprised 11 patients (mean (SD) 83 (5) years) with vasodepressor carotid sinus syndrome (either alone (eight) or in combination with significant cardioinhibition (three)) referred for investigation of unexplained syncope. Patients had experienced a median of five syncopal episodes (range two-20) over a median period of one year (range: immediately before admission to in excess of five years). Nine also complained of dizzy episodes (daily (four), twice weekly (four), and at monthly intervals (one)). Four patients had sustained a fracture during syncope. Precipitating factors for syncope were prolonged standing (three), head turning (four), looking up (three), postural changes (four) and eating (three). None was taking cardiovascular medications at the time of study; all were in sinus rhythm. Symptom free postural hypotension was present in five at one minute after head up tilt (supine systolic blood pressure 169 (23) mm Hg dropping to 136 (27) mm Hg when upright).
A > 50 mm Hg fall in systolic pressure during carotid sinus massage, independent of the cardioinhibitory response, with reproduction of symptoms, was diagnostic of vasodepressor carotid sinus syndrome.59 10 Longitudinal massage was performed over the carotid sinus, at the bifurcation of the internal and external carotid artery for six seconds. Right sided massage was followed, after a one minute interval, (to allow resetting of the gain of the baroreflex), by massage of the left carotid sinus in both the supine and 700 head up positions on the tilt table. This sequence was repeated before and three minutes after bolus doses of 600 pg of atropine given through a 20 gauge cannula in the dorsal hand vein.
Blood pressure and heart rate were continuously monitored throughout the study. Because intra-arterial cannulation may alter autonomic tone and hence cardiovascular responses to carotid sinus massage,7 noninvasive phasic blood pressure was recorded by continuous digital artery plethysmography (Finapres finger cuff). '2 Massage was repeated to ensure reproducible responses in heart rate and blood pressure. Baseline measurements were taken from an average of 10 consecutive RR intervals and blood pressure recordings. Measurements of the maximum RR interval and the maximum fall in blood pressure were used in analysis.
Subjects were then given 100 pg of fludrocortisone daily. After two weeks, the same study protocol was repeated. Patients who had a significant cardioinhibitory response before atropine, were then referred for dual chamber cardiac pacing. Recurrence of symptoms was recorded regularly during a minimum follow up of six months. Wilcoxon paired tests were used for comparison of responses before and after treatment. Results are expressed as mean (SD).
Results
The degree of vasodepressor response for both systolic and diastolic pressures was significantly reduced by fludrocortisone treatment for two weeks. The vasodepressor response was rapid: the maximum fall in systolic blood pressure occurred at 18 (3) s after carotid sinus massage and had returned to baseline by 45 (15) rate did not differ before and after treatment (table) . At six months, all patients continued to take 100 pg fludrocortisone a day. None reported side effects. All reported a considerable improvement in symptoms: nine were symptom free, none had experienced any further syncope, and two had intermittent dizzy episodes.
Discussion
Carotid sinus syndrome is increasingly recognised as a cause of unexplained falls, syncope, and dizziness in the elderly." The vasodepressor component of the syndrome is less often diagnosed as it requires simultaneous beat to beat monitoring of arterial blood pressure, which is both invasive and time consuming. Non-invasive arterial monitoring with continuous digital artery plethysmography has the advantages of convenience, speed, and accuracy, and does not alter underlying autonomic tone, unlike arterial cannulation.7"2 In our study, the maximum fall in arterial pressure occurred rapidly and pressures had returned to baseline within one minute, thus emphasising the brevity of the hypotensive response and the need for phasic blood pressure monitoring to detect changes.
Mixed cardioinhibitory and vasodepressor carotid. sinus syndrome is best treated by dual chamber cardiac pacing. ' The rationale for treatment of vasodepressor symptoms wit0h fludrocortisone is because of the overlap between the diagnoses of vasodepressor carotid sinus syndrome and orthostatic hypotension. In one series, 30% of patients with vasodepressor carotid sinus syndrome also had orthostatic hypotension2 and Brignole et al found poorer responses to single ventricular chamber pacing for relief of symptoms in patients with both conditions.'
Previous pharmacological studies have shown that in orthostatic hypotension there is both impairment of noradrenaline release from sympathetic nerve endings and denervation supersensitivity of vascular a receptors. '8 As these receptors are the affectors of the sympathetic system, they are essential to the regulation of vascular tone and blood pressure. Fludrocortisone increases pressor sensitivity to circulating catecholamines and angiotensin, alters intravascular volumes, and may have central adrenergic effects.78 Fludrocortisone may benefit both orthostatic hypotension and vasodepressor carotid sinus syndrome by one or all of these mechanisms.
The significant reduction in vasodepressor response cannot be attributed to less noticeable reductions in heart rate: the maximum RR interval did not shorten after treatment. Fludrocortisone treatment for six months was well tolerated with considerable improvement of symptoms. Diastolic blood pressure was not greatly altered by treatment although the vasodepressor diastolic response was reduced.
Fludrocortisone effectively reduces the vasodepressor response and relieves symptoms in vasodepressor carotid sinus syndome.
